Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ALI
Altitude Resources
C$0.05
-9.1%
C$0.05
C$0.03
C$0.09
C$110KN/A42,560 shs1,000 shs
ATT
Abattis Bioceuticals
C$0.00
C$0.05
C$0.74
N/AN/A1.42 million shsN/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ALI
Altitude Resources
0.00%0.00%0.00%0.00%0.00%
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ALI
Altitude Resources
N/AN/AN/AN/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ALI
Altitude Resources
0.00
N/AN/AN/A
ATT
Abattis Bioceuticals
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ALI
Altitude Resources
N/AN/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ALI
Altitude Resources
N/AN/A0.00N/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ALI
Altitude Resources
N/AN/AN/AN/AN/A
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ALI
Altitude Resources
N/A
ATT
Abattis Bioceuticals
N/A

Insider Ownership

CompanyInsider Ownership
ALI
Altitude Resources
N/A
ATT
Abattis Bioceuticals
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ALI
Altitude Resources
N/A2.20 millionN/ANot Optionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable

Top Headlines

View All Headlines

Altitude Resources CVE:ALI

C$0.05 -0.01 (-9.09%)
As of 05/16/2018

Altitude Resources Inc., a junior coal exploration company, engages in the exploration and development of coking coal properties in Alberta, Canada. It owns a 100% interest in the Palisades coal project that consists of six contiguous leases covering an area of 4,648 hectares located in the northwest of Hinton. The company is based in Calgary, Canada.

Abattis Bioceuticals CNSX:ATT

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.